Work

Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody–Drug Conjugate for Enhanced Antitumor Efficacy in Solid Tumors

Year: 2024

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-24-0319

Authors: Zeng Wang, Meijun Zheng, Mengyao Li, Huaqing Lu, Nanxi Liu, Yongdong Chen, Nian Yang, Wanqin Zeng, Yijun Dong, Jia Li, Zhixiong Zhu, Chen Yang, Zongliang Zhang, Qizhong Lu, Hexian Li, Liangxue Zhou, Hui Yang, Aiping Tong

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy, West China Medical Center of Sichuan University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, National Key Research and Development Program of China

Awards: G1263850406, G2210883228

OpenAlex ID: W4404773644

FWCI: 3.23

Cites: 41

Cited by: 14

Related to: 10